← ANALYST RATINGS · TIPRANKS
Medline (MDLN): analyst forecast and price target
Analyst consensus
Strong Buy11 Buy2 Hold0 Sell
Ratings of 13 analysts in the last 3 months · top analysts only12-month forecast
Based on 13 price targets given in the last 3 months, the average target is $43.42, the highest $55.00, the lowest $34.00. The average is +20.7% from the last price of $35.96.
Analyst ratings 27
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Glen Santangelo★★★★★★★★★★#2956 · hits 52% · avg +4.5% | Barclays | $45.00 → $43.00−4.4% | Buy | +19.6% | Reiterated | 09.10.26on TipRanks 05:15 | +0.9%next day −1.3% · 5 days +1.1% | |
| Michael Cherny★★★★★★★★★★#2074 · hits 57% · avg +5.7% | Leerink Partners | $43.00 | Buy | +19.6% | Reiterated | 07.10.26on TipRanks Oct 8 05:25 | 0.0%next day +1.2% · 5 days +2.3% | ↗ |
| Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% | RBC Capital | $46.00 | Buy | +27.9% | Reiterated | 06.10.26on TipRanks 21:45 | 0.0%next day +1.2% · 5 days +2.3% | ↗ |
| Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% | UBS | $45.00 → $43.00−4.4% | Buy | +19.6% | Assigned | 25.09.26on TipRanks 09:30 | −0.4%next day +1.8% · 5 days +2.8% | ↗ |
| Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% | William Blair | — | Buy | — | Reiterated | 23.09.26on TipRanks 06:15 | +0.3%next day +1.1% · 5 days +1.8% | ↗ |
| Jailendra Singh★★★★★★★★★★#12131 · hits 43% · avg −6.4% | Truist Financial | — | Buy | — | Reiterated | 22.09.26on TipRanks 08:45 | +7.7%next day +0.3% · 5 days +2.8% | ↗ |
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $34.00 | Hold | −5.5% | Reiterated | 21.09.26on TipRanks 14:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $35.00 | Buy | −2.7% | Reiterated | 21.09.26on TipRanks 14:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $34.00 | Hold | −5.5% | Reiterated | 21.09.26on TipRanks 14:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $33.00 | Hold | −8.2% | Reiterated | 21.09.26on TipRanks 14:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $35.00 | Buy | −2.7% | Reiterated | 21.09.26on TipRanks 14:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $37.00 | Buy | +2.9% | Reiterated | 21.09.26on TipRanks 14:05 | — | |
| David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% | BTIG | $55.00 | Buy | +52.9% | Reiterated | 27.08.26on TipRanks 07:10 | −0.5%next day +2.0% · 5 days +5.3% | ↗ |
| Ivan Feinseth★★★★★★★★★★#902 · hits 57% · avg +9.4% | Tigress Financial | $62.00 → $55.00−11.3% | Buy | +52.9% | Reiterated | 14.08.26on TipRanks Aug 11 09:36 | +4.0%next day +1.1% · 5 days −2.2% | ↗ |
| Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% | J.P. Morgan | $53.00 → $46.00−13.2% | Buy | +27.9% | Reiterated | 12.08.26on TipRanks 07:55 | +1.1%next day −0.5% · 5 days −4.0% | ↗ |
| Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% | Wells Fargo | $45.00 → $34.00−24.4% | Hold | −5.5% | Assigned | 11.08.26on TipRanks 06:55 | +4.0%next day +1.1% · 5 days −2.2% | ↗ |
| Charles Rhyee★★★★★★★★★★#1937 · hits 54% · avg +5.6% | TD Cowen | $53.00 → $45.00−15.1% | Buy | +25.1% | Assigned | 10.08.26on TipRanks Aug 9 23:11 | −4.0%next day +4.0% · 5 days +3.2% | ↗ |
| Andrew Obin★★★★★★★★★★#119 · hits 70% · avg +18.9% | Bank of America Securities | — | Buy | — | Reiterated | 06.08.26on TipRanks 15:05 | −5.7%next day +1.5% · 5 days +1.9% | ↗ |
| Eric Coldwell★★★★★★★★★★#1091 · hits 59% · avg +7.7% | Robert W. Baird | $45.00 → $42.00−6.7% | Buy | +16.8% | Reiterated | 06.08.26on TipRanks 09:30 | −5.7%next day +1.5% · 5 days +1.9% | ↗ |
| Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% | Evercore ISI | $48.00 → $39.00−18.8% | Buy | +8.5% | Reiterated | 06.08.26on TipRanks 09:01 | −5.7%next day +1.5% · 5 days +1.9% | ↗ |
| Rick Wise★★★★★★★★★★#7800 · hits 51% · avg +0.1% | Stifel Nicolaus | $50.00 → $45.00−10.0% | Buy | +25.1% | Assigned | 06.08.26on TipRanks 07:55 | −5.7%next day +1.5% · 5 days +1.9% | ↗ |
| Steven Valiquette★★★★★★★★★★#8240 · hits 53% · avg 0.0% | Mizuho Securities | $53.00 → $48.00−9.4% | Buy | +33.5% | Reiterated | 06.08.26on TipRanks 07:25 | −5.7%next day +1.5% · 5 days +1.9% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $52.00 → $48.00−7.7% | Buy | +33.5% | Reiterated | 06.08.26on TipRanks 07:06 | −5.7%next day +1.5% · 5 days +1.9% | ↗ |
| Pito Chickering★★★★★★★★★★#1500 · hits 61% · avg +9.8% | Deutsche Bank | $42.00 → $37.00−11.9% | Hold | +2.9% | Assigned | 06.08.26on TipRanks 04:26 | −5.7%next day +1.5% · 5 days +1.9% | ↗ |
| Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% | BMO Capital | $54.00 → $47.00−13.0% | Buy | +30.7% | Assigned | 05.08.26on TipRanks Aug 6 07:40 | −12.6%next day −5.7% · 5 days −3.5% | ↗ |
| Daniel Grosslight★★★★★★★★★★#4007 · hits 47% · avg +3.6% | Citi | $55.00 → $45.00−18.2% | Buy | +25.1% | Reiterated | 05.08.26on TipRanks 15:50 | −12.6%next day −5.7% · 5 days −3.5% | ↗ |
| Unknown Analyst | Jefferies | $53.00 | Buy | +47.4% | Reiterated | 07.05.26on TipRanks 08:50 | −0.1%next day −6.4% · 5 days −9.3% | ↗ |
| Lee Hambright★★★★★★★★★★#10167 · hits 49% · avg −1.6% | Bernstein | $56.00 → $54.00−3.6% | Buy | +50.2% | Assigned | 07.05.26on TipRanks 06:55 | −0.1%next day −6.4% · 5 days −9.3% | ↗ |
| David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% | Goldman Sachs | $50.00 | Buy | +39.0% | Reiterated | 06.05.26on TipRanks May 7 07:15 | −8.7%next day −0.1% · 5 days −9.0% | ↗ |
| Jason Bednar★★★★★★★★★★#11450 · hits 46% · avg −2.5% | Piper Sandler | $50.00 → $55.00+10.0% | Buy | +52.9% | Reiterated | 04.05.26on TipRanks 07:35 | −0.9%next day +1.8% · 5 days −14.1% | ↗ |
| Navann Ty★★★★★★★★★★#4487 · hits 56% · avg +7.4% | Exane BNP Paribas | $38.00 | Hold | +5.7% | Initiated | 12.01.26on TipRanks 08:41 | +5.3%next day +0.5% · 5 days +5.9% | ↗ |
| Michael Polark★★★★★★★★★★#2909 · hits 51% · avg +6.5% | Wolfe Research | $47.00 | Buy | +30.7% | Initiated | 12.01.26on TipRanks 08:41 | +5.3%next day +0.5% · 5 days +5.9% | ↗ |
| Ed Ridley-Day★★★★★★★★★★#5780 · hits 54% · avg +8.0% | Rothschild & Co Redburn | $42.00 | Hold | +16.8% | Initiated | 12.01.26on TipRanks 07:31 | +5.3%next day +0.5% · 5 days +5.9% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Medline
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 06.10.26: target $44.88 at a price of $35.80 (+25.4%); now: $44.76 at $35.96 (+24.5%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 15 | 13 | 14 | 15 | 14 | 14 |
| Hold | 3 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 04.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.34 (from $0.28 to $0.41). Last quarter: $0.50.
Sales
Next quarter’s sales estimate — $7.7B (from $7.7B to $7.9B). Last quarter: $7.7B.
Best top-analyst consensus in the sector · General
About Medline
- CEO: James Boyle
- Employees: 45,000
- 3 Lakes Drive, Northfield, IL, 60093, US
- www.medline.com
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technolo
Data from the stock’s TipRanks forecast page, read 0 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗